The insulin receptor substrate-1: a biomarker for cancer?
- PMID: 18851963
- DOI: 10.1016/j.yexcr.2008.09.017
The insulin receptor substrate-1: a biomarker for cancer?
Abstract
This review focuses on IRS-1 and the evidence of its role in cell transformation. The literature strongly suggests that IRS-1 should be considered a biomaker for cancers susceptible to IGF-IR targeting. In addition, I would like to propose that IRS-1 may have a more general role in cancer, and could be considered as a protein having the opposite effect of tumor suppressors, a sort of anti-p53 molecule.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
